Antibiotic combination therapy against resistant bacterial infections: synergy, rejuvenation and resistance reduction

International Consensus Guidelines for the Optimal Use of the Polymyxins: Endorsed by the American College of Clinical Pharmacy (ACCP), European Society of Clinical Microbiology and Infectious Diseases (ESCMID), Infectious Diseases Society of America (IDSA), International Society for Anti‐infective Pharmacology (ISAP), Society of Critical Care Medicine (SCCM), and Society of Infectious Diseases Pharmacists (SIDP)

(2019) Brian T. Tsuji et al.   PHARMACOTHERAPY

Bedaquiline kills persistent Mycobacterium tuberculosis with no disease relapse: an in vivo model of a potential cure

(2019) Yanmin Hu et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

In vitro activity of ampicillin and ceftriaxone against ampicillin-susceptible Enterococcus faecium

(2019) Michael P Lorenzo et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

An Examination of Flying Insects in Seven Hospitals in the United Kingdom and Carriage of Bacteria by True Flies (Diptera: Calliphoridae, Dolichopodidae, Fanniidae, Muscidae, Phoridae, Psychodidae, Sphaeroceridae)

(2019) Federica Boiocchi et al.   JOURNAL OF MEDICAL ENTOMOLOGY

Correction: ACG Clinical Guideline: Treatment of Helicobacter pylori Infection

(2018) William D. Chey et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Prevention of High-Level Daptomycin-Resistance Emergence In Vitro in Streptococcus mitis-oralis by Using Combination Antimicrobial Strategies

(2018) Brianne Zapata et al.   CURRENT MICROBIOLOGY

Colistin alone versus colistin plus meropenem for treatment of severe infections caused by carbapenem-resistant Gram-negative bacteria: an open-label, randomised controlled trial

(2018) Mical Paul et al.   LANCET INFECTIOUS DISEASES

Pembrolizumab plus Chemotherapy in Metastatic Non–Small-Cell Lung Cancer

(2018) Leena Gandhi et al.   NEW ENGLAND JOURNAL OF MEDICINE

Synergistic combination of two antimicrobial agents closing each other’s mutant selection windows to prevent antimicrobial resistance

(2018) Xuejie Xu et al.   Scientific Reports

Increasing evidence of potential toxicity of a common antibiotic combination

(2018) Morgan Scully et al.   Journal of Infection and Public Health

Serum bactericidal activity of colistin and azidothymidine combinations against mcr-1 positive colistin-resistant Escherichia coli

(2018) Maria Loose et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Partial Oral versus Intravenous Antibiotic Treatment of Endocarditis

(2018) Kasper Iversen et al.   NEW ENGLAND JOURNAL OF MEDICINE

Drug Resistance Driven by Cancer Stem Cells and Their Niche

(2017) Marta Prieto-Vila et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Suppressive drug combinations and their potential to combat antibiotic resistance

(2017) Nina Singh et al.   JOURNAL OF ANTIBIOTICS

Pharmacodynamics of colistin and fosfomycin: a ‘treasure trove’ combination combats KPC-producing Klebsiella pneumoniae

(2017) Miao Zhao et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Polymyxin-resistant, carbapenem-resistant Acinetobacter baumannii is eradicated by a triple combination of agents that lack individual activity

(2017) Justin R. Lenhard et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Efficacy and Toxicity of Different Chemotherapy Regimens in the Treatment of Advanced or Metastatic Pancreatic Cancer: A Network Meta-Analysis

(2017) Gui-Feng Liu et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

Rationalizing combination therapies

(2017)   NATURE MEDICINE

Polymyxin Combinations Combat Escherichia coli Harboring mcr-1 and bla NDM-5 : Preparation for a Postantibiotic Era

(2017) Zackery P. Bulman et al.   mBio

Origins of Combination Therapy for Tuberculosis: Lessons for Future Antimicrobial Development and Application

(2017) Christopher A. Kerantzas et al.   mBio

Overview on mechanisms of isoniazid action and resistance in Mycobacterium tuberculosis

(2016) Ameeruddin Nusrath Unissa et al.   INFECTION GENETICS AND EVOLUTION

Antibiotic combination therapy can select for broad-spectrum multidrug resistance in Pseudomonas aeruginosa

(2016) Martin Vestergaard et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Enhanced identification of synergistic and antagonistic emergent interactions among three or more drugs

(2016) Elif Tekin et al.   Journal of the Royal Society Interface

Uncovering emergent interactions in three-way combinations of stressors

(2016) Casey Beppler et al.   Journal of the Royal Society Interface

CAMERA2 – combination antibiotic therapy for methicillin-resistant Staphylococcus aureus infection: study protocol for a randomised controlled trial

(2016) Steven Y. C. Tong et al.   Trials

World Cancer Report 2014. Geneva, Switzerland: World Health Organization, International Agency for Research on Cancer, WHO Press, 2015

(2016) Shelley McGuire   Advances in Nutrition

Polymyxin B in Combination with Antimicrobials LackingIn VitroActivity versus Polymyxin B in Monotherapy in Critically Ill Patients with Acinetobacter baumannii or Pseudomonas aeruginosa Infections

(2015) Maria Helena Rigatto et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Antimicrobial Peptide Novicidin Synergizes with Rifampin, Ceftriaxone, and Ceftazidime against Antibiotic-Resistant EnterobacteriaceaeIn Vitro

(2015) Odel Soren et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Antimicrobial interactions: mechanisms and implications for drug discovery and resistance evolution

(2015) Tobias Bollenbach   CURRENT OPINION IN MICROBIOLOGY

2015 ESC Guidelines for the management of infective endocarditis

(2015) Gilbert Habib et al.   EUROPEAN HEART JOURNAL

Tackling antibiotic resistance: the environmental framework

(2015) Thomas U. Berendonk et al.   NATURE REVIEWS MICROBIOLOGY

Same Exposure but Two Radically Different Responses to Antibiotics: Resilience of the Salivary Microbiome versus Long-Term Microbial Shifts in Feces

(2015) E. Zaura et al.   mBio

Extremely High Mutation Rate of HIV-1 In Vivo

(2015) José M. Cuevas et al.   PLOS BIOLOGY

High-dose rifampicin kills persisters, shortens treatment duration, and reduces relapse rate in vitro and in vivo

(2015) Yanmin Hu et al.   Frontiers in Microbiology

Preliminary Study of Colistin versus Colistin plus Fosfomycin for Treatment of Carbapenem-Resistant Acinetobacter baumannii Infections

(2014) Rujipas Sirijatuphat et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Synergistic Interactions of Vancomycin with Different Antibiotics against Escherichia coli: Trimethoprim and Nitrofurantoin Display Strong Synergies with Vancomycin against Wild-Type E. coli

(2014) Alice Zhou et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Characteristics, risk factors and outcomes of adult cancer patients with extensively drug-resistant Pseudomonas aeruginosa infections

(2014) G. Samonis et al.   INFECTION

When Does 2 Plus 2 Equal 5? A Review of Antimicrobial Synergy Testing

(2014) C. D. Doern   JOURNAL OF CLINICAL MICROBIOLOGY

Analysis of Combination Drug Therapy to Develop Regimens with Shortened Duration of Treatment for Tuberculosis

(2014) George L. Drusano et al.   PLoS One

Prediction of resistance development against drug combinations by collateral responses to component drugs

(2014) C. Munck et al.   Science Translational Medicine

Association Between Hemodynamic Presentation and Outcome in Sepsis Patients

(2014) Sung Yeon Hwang et al.   SHOCK

Colistin and Rifampicin Compared With Colistin Alone for the Treatment of Serious Infections Due to Extensively Drug-Resistant Acinetobacter baumannii: A Multicenter, Randomized Clinical Trial

(2013) Emanuele Durante-Mangoni et al.   CLINICAL INFECTIOUS DISEASES

The end of AIDS: HIV infection as a chronic disease

(2013) Steven G Deeks et al.   LANCET

In VitroSynergy of Colistin Combinations against Colistin-Resistant Acinetobacter baumannii, Pseudomonas aeruginosa, and Klebsiella pneumoniae Isolates

(2012) Céline Vidaillac et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Combination Therapy for Treatment of Infections with Gram-Negative Bacteria

(2012) P. D. Tamma et al.   CLINICAL MICROBIOLOGY REVIEWS

Tuberculous Endocarditis

(2012) Alexander Liu et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Natural antimicrobial peptides from bacteria: characteristics and potential applications to fight against antibiotic resistance

(2012) M. Hassan et al.   JOURNAL OF APPLIED MICROBIOLOGY

The challenge of Helicobacter pylori resistance to antibiotics: the comeback of bismuth-based quadruple therapy

(2012) Francis Mégraud   Therapeutic Advances in Gastroenterology

Combination therapies for combating antimicrobial resistance

(2011) Michael A Fischbach   CURRENT OPINION IN MICROBIOLOGY

Combination antibiotic therapy for community-acquired pneumonia

(2011) Jesus Caballero et al.   Annals of Intensive Care

Defining Fractional Inhibitory Concentration Index Cutoffs for Additive Interactions Based on Self-Drug Additive Combinations, Monte Carlo Simulation Analysis, and In Vitro-In Vivo Correlation Data for Antifungal Drug Combinations against Aspergillus fumigatus

(2009) J. Meletiadis et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Resident Microbiota of the Gypsy Moth Midgut Harbors Antibiotic Resistance Determinants

(2009) Heather K. Allen et al.   DNA AND CELL BIOLOGY

Colistin therapy for microbiologically documented multidrug-resistant Gram-negative bacterial infections: a retrospective cohort study of 258 patients

(2009) Matthew E. Falagas et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS